List of Tables
Table 1. Global Anthrax Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anthrax Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anthrax Treatment Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anthrax Treatment Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anthrax Treatment Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anthrax Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anthrax Treatment Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anthrax Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anthrax Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anthrax Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anthrax Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Anthrax Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anthrax Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthrax Treatment as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anthrax Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anthrax Treatment Sales by Region (2020-2025) & (K Units)
Table 18. Global Anthrax Treatment Sales Market Share by Region (2020-2025)
Table 19. Global Anthrax Treatment Sales by Region (2026-2031) & (K Units)
Table 20. Global Anthrax Treatment Sales Market Share by Region (2026-2031)
Table 21. Global Anthrax Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anthrax Treatment Revenue Market Share by Region (2020-2025)
Table 23. Global Anthrax Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anthrax Treatment Revenue Market Share by Region (2026-2031)
Table 25. North America Anthrax Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anthrax Treatment Sales by Country (2020-2025) & (K Units)
Table 27. North America Anthrax Treatment Sales by Country (2026-2031) & (K Units)
Table 28. North America Anthrax Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anthrax Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anthrax Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anthrax Treatment Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anthrax Treatment Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anthrax Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anthrax Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anthrax Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anthrax Treatment Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anthrax Treatment Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anthrax Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anthrax Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anthrax Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anthrax Treatment Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anthrax Treatment Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anthrax Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anthrax Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anthrax Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anthrax Treatment Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anthrax Treatment Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anthrax Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anthrax Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anthrax Treatment Sales (K Units) by Type (2020-2025)
Table 51. Global Anthrax Treatment Sales (K Units) by Type (2026-2031)
Table 52. Global Anthrax Treatment Sales Market Share by Type (2020-2025)
Table 53. Global Anthrax Treatment Sales Market Share by Type (2026-2031)
Table 54. Global Anthrax Treatment Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anthrax Treatment Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anthrax Treatment Revenue Market Share by Type (2020-2025)
Table 57. Global Anthrax Treatment Revenue Market Share by Type (2026-2031)
Table 58. Global Anthrax Treatment Price (US$/Unit) by Type (2020-2025)
Table 59. Global Anthrax Treatment Price (US$/Unit) by Type (2026-2031)
Table 60. Global Anthrax Treatment Sales (K Units) by Application (2020-2025)
Table 61. Global Anthrax Treatment Sales (K Units) by Application (2026-2031)
Table 62. Global Anthrax Treatment Sales Market Share by Application (2020-2025)
Table 63. Global Anthrax Treatment Sales Market Share by Application (2026-2031)
Table 64. Global Anthrax Treatment Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anthrax Treatment Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anthrax Treatment Revenue Market Share by Application (2020-2025)
Table 67. Global Anthrax Treatment Revenue Market Share by Application (2026-2031)
Table 68. Global Anthrax Treatment Price (US$/Unit) by Application (2020-2025)
Table 69. Global Anthrax Treatment Price (US$/Unit) by Application (2026-2031)
Table 70. Alembic Pharmaceuticals Company Information
Table 71. Alembic Pharmaceuticals Description and Business Overview
Table 72. Alembic Pharmaceuticals Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Alembic Pharmaceuticals Anthrax Treatment Product
Table 74. Alembic Pharmaceuticals Recent Developments/Updates
Table 75. Integrated Bio Therapeutics Inc. Company Information
Table 76. Integrated Bio Therapeutics Inc. Description and Business Overview
Table 77. Integrated Bio Therapeutics Inc. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Integrated Bio Therapeutics Inc. Anthrax Treatment Product
Table 79. Integrated Bio Therapeutics Inc. Recent Developments/Updates
Table 80. Sun Pharmaceutical Industries Ltd. Company Information
Table 81. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 82. Sun Pharmaceutical Industries Ltd. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sun Pharmaceutical Industries Ltd. Anthrax Treatment Product
Table 84. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 85. Zydus Group Company Information
Table 86. Zydus Group Description and Business Overview
Table 87. Zydus Group Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Zydus Group Anthrax Treatment Product
Table 89. Zydus Group Recent Developments/Updates
Table 90. Bayer AG Company Information
Table 91. Bayer AG Description and Business Overview
Table 92. Bayer AG Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Bayer AG Anthrax Treatment Product
Table 94. Bayer AG Recent Developments/Updates
Table 95. Pfizer Inc. Company Information
Table 96. Pfizer Inc. Description and Business Overview
Table 97. Pfizer Inc. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer Inc. Anthrax Treatment Product
Table 99. Pfizer Inc. Recent Developments/Updates
Table 100. EMERGENT Company Information
Table 101. EMERGENT Description and Business Overview
Table 102. EMERGENT Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. EMERGENT Anthrax Treatment Product
Table 104. EMERGENT Recent Developments/Updates
Table 105. Sanofi Company Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Sanofi Anthrax Treatment Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Elusys Therapeutics Company Information
Table 111. Elusys Therapeutics Description and Business Overview
Table 112. Elusys Therapeutics Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Elusys Therapeutics Anthrax Treatment Product
Table 114. Elusys Therapeutics Recent Developments/Updates
Table 115. Porton Biopharma Company Information
Table 116. Porton Biopharma Description and Business Overview
Table 117. Porton Biopharma Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Porton Biopharma Anthrax Treatment Product
Table 119. Porton Biopharma Recent Developments/Updates
Table 120. Lupin Company Information
Table 121. Lupin Description and Business Overview
Table 122. Lupin Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Lupin Anthrax Treatment Product
Table 124. Lupin Recent Developments/Updates
Table 125. Soligenix Company Information
Table 126. Soligenix Description and Business Overview
Table 127. Soligenix Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Soligenix Anthrax Treatment Product
Table 129. Soligenix Recent Developments/Updates
Table 130. Takeda Pharmaceutical Company Limited Company Information
Table 131. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 132. Takeda Pharmaceutical Company Limited Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Takeda Pharmaceutical Company Limited Anthrax Treatment Product
Table 134. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 135. Teva Pharmaceutical Industries Ltd. Company Information
Table 136. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 137. Teva Pharmaceutical Industries Ltd. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Teva Pharmaceutical Industries Ltd. Anthrax Treatment Product
Table 139. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 140. ARISTO Pharmaceuticals Private Limited Company Information
Table 141. ARISTO Pharmaceuticals Private Limited Description and Business Overview
Table 142. ARISTO Pharmaceuticals Private Limited Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. ARISTO Pharmaceuticals Private Limited Anthrax Treatment Product
Table 144. ARISTO Pharmaceuticals Private Limited Recent Developments/Updates
Table 145. INDOCO REMEDIES LTD. Company Information
Table 146. INDOCO REMEDIES LTD. Description and Business Overview
Table 147. INDOCO REMEDIES LTD. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. INDOCO REMEDIES LTD. Anthrax Treatment Product
Table 149. INDOCO REMEDIES LTD. Recent Developments/Updates
Table 150. Paratek Pharmaceuticals, Inc. Company Information
Table 151. Paratek Pharmaceuticals, Inc. Description and Business Overview
Table 152. Paratek Pharmaceuticals, Inc. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Paratek Pharmaceuticals, Inc. Anthrax Treatment Product
Table 154. Paratek Pharmaceuticals, Inc. Recent Developments/Updates
Table 155. DEINOVE Company Information
Table 156. DEINOVE Description and Business Overview
Table 157. DEINOVE Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. DEINOVE Anthrax Treatment Product
Table 159. DEINOVE Recent Developments/Updates
Table 160. BlueWillow Biologics. Company Information
Table 161. BlueWillow Biologics. Description and Business Overview
Table 162. BlueWillow Biologics. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. BlueWillow Biologics. Anthrax Treatment Product
Table 164. BlueWillow Biologics. Recent Developments/Updates
Table 165. GC Biopharma, corp. Company Information
Table 166. GC Biopharma, corp. Description and Business Overview
Table 167. GC Biopharma, corp. Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. GC Biopharma, corp. Anthrax Treatment Product
Table 169. GC Biopharma, corp. Recent Developments/Updates
Table 170. Altimmune Company Information
Table 171. Altimmune Description and Business Overview
Table 172. Altimmune Anthrax Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Altimmune Anthrax Treatment Product
Table 174. Altimmune Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Anthrax Treatment Distributors List
Table 178. Anthrax Treatment Customers List
Table 179. Anthrax Treatment Market Trends
Table 180. Anthrax Treatment Market Drivers
Table 181. Anthrax Treatment Market Challenges
Table 182. Anthrax Treatment Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anthrax Treatment
Figure 2. Global Anthrax Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anthrax Treatment Market Share by Type: 2024 & 2031
Figure 4. Fluoroquinolone Product Picture
Figure 5. Tetracycline Product Picture
Figure 6. Others Product Picture
Figure 7. Global Anthrax Treatment Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Anthrax Treatment Market Share by Application: 2024 & 2031
Figure 9. Hospitals Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Anthrax Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Anthrax Treatment Market Size (2020-2031) & (US$ Million)
Figure 14. Global Anthrax Treatment Sales (2020-2031) & (K Units)
Figure 15. Global Anthrax Treatment Average Price (US$/Unit) & (2020-2031)
Figure 16. Anthrax Treatment Report Years Considered
Figure 17. Anthrax Treatment Sales Share by Manufacturers in 2024
Figure 18. Global Anthrax Treatment Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Anthrax Treatment Players: Market Share by Revenue in Anthrax Treatment in 2024
Figure 20. Anthrax Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Anthrax Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Anthrax Treatment Sales Market Share by Country (2020-2031)
Figure 23. North America Anthrax Treatment Revenue Market Share by Country (2020-2031)
Figure 24. United States Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Anthrax Treatment Sales Market Share by Country (2020-2031)
Figure 27. Europe Anthrax Treatment Revenue Market Share by Country (2020-2031)
Figure 28. Germany Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Anthrax Treatment Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Anthrax Treatment Revenue Market Share by Region (2020-2031)
Figure 35. China Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Anthrax Treatment Sales Market Share by Country (2020-2031)
Figure 43. Latin America Anthrax Treatment Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Anthrax Treatment Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Anthrax Treatment Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Anthrax Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Anthrax Treatment by Type (2020-2031)
Figure 53. Global Revenue Market Share of Anthrax Treatment by Type (2020-2031)
Figure 54. Global Anthrax Treatment Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Anthrax Treatment by Application (2020-2031)
Figure 56. Global Revenue Market Share of Anthrax Treatment by Application (2020-2031)
Figure 57. Global Anthrax Treatment Price (US$/Unit) by Application (2020-2031)
Figure 58. Anthrax Treatment Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
